Concepedia

Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

A. Roth, Rudolf Maibach, Giovanni Martinelli, Nicola Fazio, Matti Aapro, Olivia Pagani, R. Morant, Markus Borner, R. Herrmann, Hanspeter Honegger,

Annals of Oncology · 2000 · 207 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

, , +15

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

André M. Murad, Flávia Ferretti Santiago, Andy Petroianu et al. · Cancer · 1993 · 793 citations · Full text

, , +17

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

J. Wils, H. O. Klein, D. J. Th. Wagener et al. · Journal of Clinical Oncology · 1991 · 392 citations · Full text

, , +12

Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems

H.‐J. Kock, M. Pietsch, Ulla Krause et al. · World Journal of Surgery · 1998 · 386 citations

, , +10